Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRospEctiVe charactErization of Asthma Patients Treated With DupilumAb in reaL World Setting

NCT04550962 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT04550962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04550962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRospEctiVe charactErization of Asthma Patients Treated With DupilumAb in reaL World Setting
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
November 2, 2020
Completion date
June 18, 2026
Enrollment
376 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

asthma